Patient Preferences: PARPi vs Standard Chemo - Clinical Trial
What is the Purpose of this Study?
We are doing this study to learn which medicine that women diagnosed with ovarian, fallopian tube, or peritoneal cancer prefer to take.
Ovarian, Fallopian Tube, or Peritoneal Cancer
Who Can Participate in the Study?
Adult women who:
- Have been diagnosed with ovarian, fallopian tube, or peritoneal cancer
- Have gotten chemotherapy treatment
What is Involved?
If you choose to join this study, you will:
-Complete a survey about new medication treatment such as side effects, costs, and the chances that the medication will work at different times during treatment